Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

20150129 smb nemo healthcare

494 views

Published on

  • Be the first to comment

  • Be the first to like this

20150129 smb nemo healthcare

  1. 1. Science meets Business Health technology assessment January 29, 2015 Confidential Safe births Healthy children
  2. 2. Ambition: What if we could reduce birth asphyxia with 50%? • Save 20.000 newborns yearly from starting with a handicap • Deliver €10B cost of care savings to society • Build a great enterprise with €100M+ revenues Confidential Guess what, we can! But HOW to achieve that goal???
  3. 3. What we believe (and know, of course...) 1) We are the best, we can do this... 2) Yes, absolutely, you need to invest in us... 3) This is huge... 4) It will be all right, trust me... Confidential
  4. 4. What ‘they’ see... Technology development takes (too) long... Underfunded, but they get there: CE marking (2013) They’re halfway there... Now prove they can sell... Confidential
  5. 5. 1) We need users (to prove we can sell) 2) Users want scientific proof 3) We need users to provide scientific proof... See 1) Confidential Paradox
  6. 6. Vicious circle Confidential
  7. 7. How to break these chains? Health technology assessment Confidential
  8. 8. MedValueTechnology assessment What can PUREtrace bring: • Cost savings? • Reduce C-sections? • Convince decision makers? • ... Confidential
  9. 9. CTG tracing showed drop in FHR (blue arrow), emergency C-section would be logical next step. PUREtrace indicated non-relaxing uterine muscle (red arrow). Oxytocin was stopped and the fetus recovered. Eventually, the child was delivered vaginally (data MMC Veldhoven). Data from HIS MMC Veldhoven Confidential Example
  10. 10. Output • Independent proof through solid research • Radboud UMC connected • Access to insurers • Validation options • Network • ... Confidential
  11. 11. HTA provides • Early stage screening • Early stage proof (at limited costs) • Independent support • Improvement plans Confidential
  12. 12. HISTORY Confidential

×